Your search returned 3 results.

Results
	1.	Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. MedStar authors: Epstein, Stephen E Lipinski, Michael J PMID: 27856497 Year: 2017 Citation: Circulation Research. 120(2):332-340, 2017 Jan 20 Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Anderson AS, Butler J, Cole RT, Epstein SE, Gheorghiade M, Greene SJ, Kim RJ, Ko YA, Lipinski MJ, Margulies KB, Quyyumi AA, Sikora S, Skopicki HA, Tankovich NI, Wilcox JE DOI: https://dx.doi.org/10.1161/CIRCRESAHA.116.309717 Add to cart (remove)
	2.	Tumor necrosis factor-alpha inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: Adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device. MedStar authors: Krishnan, Mrinalini Sheikh, Farooq PMID: 32830024 Year: 2020 Citation: Journal of Heart & Lung Transplantation. 39(12):1504-1505, 2020 12. Institution: MedStar Heart & Vascular Institute Medline publication type: Letter Form of publication: Journal Article All authors: Cupps TR, Krishnan M, Sheikh FH DOI: https://dx.doi.org/10.1016/j.healun.2020.08.001 Add to cart (remove)
	3.	In-Hospital Complications in Pregnant Women With Current or Historical Cancer Diagnoses. MedStar authors: Barac, Ana PMID: 34272068 Year: 2021 Citation: Mayo Clinic Proceedings. 96(11):2779-2792, 2021 11. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Barac A, Chappell LC, Chew-Graham CA, Jordan KP, Lundberg GP, Maas AHEM, Mamas MA, Michos ED, Mohamed MO, Wu P DOI: https://dx.doi.org/10.1016/j.mayocp.2021.03.038 Add to cart (remove)

Powered by Koha